Global Patent Index - EP 0397798 A1

EP 0397798 A1 19901122 - THERAPEUTIC USE OF ANTI-T CELL IMMUNOTOXIN FOR AUTOIMMUNE DISEASES.

Title (en)

THERAPEUTIC USE OF ANTI-T CELL IMMUNOTOXIN FOR AUTOIMMUNE DISEASES.

Title (de)

VERWENDUNG VON ANTI-I-ZELLEN-IMMUNOTOXIN FÜR AUTOIMMUNE KRANKHEITEN.

Title (fr)

UTILISATION THERAPEUTIQUE D'IMMUNOTOXIQUES ANTI-CELLULES T CONTRE DES MALADIES AUTOIMMUNES.

Publication

EP 0397798 A1 19901122 (EN)

Application

EP 89902872 A 19890203

Priority

US 15174488 A 19880203

Abstract (en)

[origin: WO8906968A1] A method and therapeutic composition for the treatment of autoimmune disease by the administration of an anti-T cell immunotoxin comprising a cytotoxic agent conjugated to an anti-T cell immunoglobulin.

Abstract (fr)

Un procédé et une composition thérapeutique destinés au traitement de maladies auto-immunes, par l'administration d'une immunotoxine anti-cellules T comprenant un agent cytotoxique conjugué avec une immunoglobine anti-cellules T.

IPC 1-7

A61K 37/00; A61K 37/24; A61K 39/00; A61K 39/395; A61K 45/02

IPC 8 full level

C12P 21/08 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 47/48 (2006.01); A61P 29/00 (2006.01); A61P 37/06 (2006.01); C07K 14/00 (2006.01); C07K 14/415 (2006.01); C07K 14/42 (2006.01); C07K 14/705 (2006.01); C07K 14/715 (2006.01); C07K 16/00 (2006.01); C07K 19/00 (2006.01); C12R 1/91 (2006.01)

CPC (source: EP)

A61K 47/6817 (2017.07); A61P 29/00 (2017.12); A61P 37/06 (2017.12)

Designated contracting state (EPC)

AT BE CH DE FR GB IT LI LU NL SE

DOCDB simple family (publication)

WO 8906968 A1 19890810; AU 3215789 A 19890825; AU 633251 B2 19930128; DK 184890 A 19901003; DK 184890 D0 19900802; EP 0397798 A1 19901122; EP 0397798 A4 19911030; JP H03503887 A 19910829

DOCDB simple family (application)

US 8900440 W 19890203; AU 3215789 A 19890203; DK 184890 A 19900802; EP 89902872 A 19890203; JP 50266489 A 19890203